Comments
Human Genome shareholder files case to restrain "poison pill"
29.05.2012. | (Reuters) - A Human Genome Sciences shareholder has filed a lawsuit against the board and requested a Maryland court to temporarily restrain the company from using a "poison pill" in response to GlaxoSmithKline's hostile $2.6 billion takeover offer....
